Searchable abstracts of presentations at key conferences in endocrinology

ea0009p199 | Clinical | BES2005

Pituitary failure as a presentation of previously undiagnosed metastatic lung cancer

Galliford T , Winocour P

The causes of panhypopituitarism are well known and pituitary metastases is a recognised but rare cause. It can often be difficult to diagnose because the non-specific features of malignancy mask those of pituitary involvement.We present the case of a 73 year old gentleman who complained of fatigue and weight loss. He had recently been treated for a radiographically proven bronchopneumonia. Endocrine checks suggested secondary hypothyroidism however (TSH...

ea0007p278 | Clinical case reports | BES2004

Primary hypopituitarism as a first presentation of sarcoidosis - 2 case reports

Galliford T , Hopkins D

Hypopituitarism due to neurosarcoidosis is mainly seen in patients with extensive systemic disease. However, pituitary involvement can occur without other classical features of the disease, as illustrated by the following cases.Case 1: An Afro-Caribbean male presented in 1986 with failure of pubertal development aged 22. Initial investigations demonstrated hypothalamic hypogonadism, secondary hypothyroidism and a suboptimal cortisol response to hypoglyca...

ea0004oc9 | Endocrine tumours and neoplasia | SFE2002

ROLE OF CERAMIDE SIGNALLING DURING FENRETINIDE AND RETINOIC ACID ACTION ON OVARIAN CANCER CELLS

Das T , Schrey M

Fenretinide (4-hydroxyphenyl retinamide, 4-HPR) is a synthetic retinoid that exhibits anti-neoplastic properties and clinical trials indicate a potential chemopreventative action of 4HPR in the development of ovarian cancer. Although the mechanism of 4HPR action remains largely unknown, ceramide has been recently proposed as a cellular signal.The aim of the present study is to investigate in vitro the action of 4HPR and the retinoic acid receptor ...

ea0003p246 | Steroids | BES2002

Comparison of the efficacy of long-term self-administration of subcutaneous human chorionic gonadotrophin with intramuscular exogenous testosterone (Sustanon) in male hypogonadism

Caddy S , Jones T

Male hypogonadism can occur either due to disorders at the hypothalamic or pituitary levels or as a result of primary testicular failure. Conventionally, testosterone is replaced by depot intramuscular injections of testoterone esters or as implants producing non-physiological levels of serum testosterone. Human chorionic gonadotrophin (hCG) given twice-weekly s.c., stimulates endogenous testosterone secretion through its LH like action resulting in physiological serum testost...

ea0003p276 | Thyroid | BES2002

Increased force/unit cross sectional area as well as increased bulk causes recovery in proximal strength in hyper/hypothyroidism

Khaleeli A , Houghton T

With treatment of endocrine myopathies increased proximal muscle strength is generally attributed to increased bulk. However in hypothyroid myopathy individuals have been shown to increase strength despite reduction in bulk.We studied 25 hyperthyroid and 27 hypothyroid randomly selected patients, measuring body weight, quadriceps and deltoid force using strain gauge techniques or with a myometer. Cross sectional area (CSA) of the quadriceps and Right de...

ea0002sp17 | Maternal and Fetal Responses to Environmental Challenges of Feto-Placental Function | SFE2001

ENVIRONMENTAL MANIPULATION OF FETO-PLACENTAL GROWTH AND ENDOCRINE FUNCTION

Symonds M , Stephenson T

Differential changes in placental or fetal growth can result from chronic alterations in the environment depending on their timing and duration. These include thermal stimulation and/or altered photoperiod whose effects may be mediated in part by increased maternal food intake and/or repartitioning of available nutrients across the placenta. Fetal growth can subsequently be enhanced due to increased abundance of fetal anabolic hormones including prolactin. In particular, fetal...

ea0029oc15.2 | Thyroid Basic | ICEECE2012

Ligand bound-thyroid hormone receptor contributes to reprogramming of pancreatic exocrine cells to insulin-producing cells via induction of Ngn3 and MafA

Furuya F. , Shimura H. , Endo T. , Kobayashi T.

Introduction: One goal of diabetic regenerative medicine is to instructively convert mature pancreatic exocrine cells into insulin-producing cells. We recently reported that liganded thyroid hormone receptor α (TRα) plays a critical role in expansion of the β-cell mass during postnatal development.Materials and Methods: AdTRα is a recombinant adenoviral vector that expresses human TRα1 under the control of the cytomegalovirus pro...

ea0029p46 | Adrenal cortex | ICEECE2012

Differential methylation signature in benign and malignant cortisol producing adrenocortical tumors

Akerstrom T. , Ahmad T. , Hellman P. , Bjorklund P.

Background: Adrenocortical carcinomas (ACC) are rare tumors with an incidence of 1–2 per million. Although rare, it is an aggressive endocrine cancer with poor prognosis. As of today there is no reliable diagnostic biomarker to distinguish benign tumors from malignant tumors. Global changes in DNA methylation and DNA promoter hypermethylation are important events in tumorigenesis. Promoter hypermethylation can cause silencing of tumour suppressor genes or lead to abnormal...

ea0029p333 | Cardiovascular Endocrinology and Lipid Metabolism | ICEECE2012

The effect of thyroxine replacement on reduction of small dense low-density lipoprotein (sdLDL) in patients with primary hypothyroidism.

Saito J. , Watanabe T. , Matsuzawa Y. , Omura M. , Nishikawa T.

Background: Dyslipidemia is a well-known manifestation of thyroid dysfunction and there is evidence of an association between hypothyroidism and coronary heart disease. Recently, small dense low-density lipoprotein (sdLDL) has been linked with development of cardiovascular disease. But relations between thyroid function and sdLDL remain incompletely understood.Objective: Our objective was to determine whether replacement therapy with thyroxine for patien...

ea0029p1219 | Obesity | ICEECE2012

Comparison of serum high-molecular-weight (HMW) adiponectin and homeostasis model assessment of insulin resistance (HOMA-IR) as markers for metabolic syndrome (MS) in estonian adult population

Eglit T. , Rajasalu T. , Ringmets I. , Lember M.

Introduction: The MS is a cluster of metabolic risk factors which are closely associated with insulin resistance and hypoadiponectinemia. The HMW adiponectin has been acknowledged as a predictive marker for MS. The prevalence of MS increases worldwide. Recently, the prevalence of MS among Estonian adults was estimated to be 26%. In the current study, we aimed to compare the utility of HMW adiponectin and HOMA-IR for the identification of MS.Methods: Our ...